Cutting Edge: Distinct TCR- and CD28-Derived Signals Regulate CD95L, Bcl-xL, and the Survival of Primary T Cells

Journal of Immunology

Volumn 172, Issue 3, 2004, Pages 1341-1345

  Kerstan, Andreas ^a   Hünig, Thomas ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; PROTEIN BCL X; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CELL CONTACT; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CROSS LINKING; GENE CONTROL; LYMPH NODE; LYMPHOCYTE CLONE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION;

EID: 1642444653     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.3.1341     Document Type: Article

References (27)

1. Dhein, J., H. Walczak, C. Baumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
2. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
3. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
4. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
5. Owen-Schaub, L. B., S. Yonehara, W. L. Crump III, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol. 140:197.
6. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
7. Wesselborg, S., O. Janssen, and D. Kabelitz. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338.
8. + T cells. J. Immunol. 163:1817.
9. L. Immunity 3:87.
10. Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K. M. Debatin, P. H. Krammer, and M. E. Peter. 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675.
11. Collette, Y., D. Razanajaona, M. Ghiotto, and D. Olive. 1997. CD28 can promote T cell survival through a phosphatidylinositol 3-kinase-independent mechanism. Eur. J. Immunol. 27:3283.
12. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
13. Tacke, M., G. Hanke, T. Hanke, and T. Hunig. 1997. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur. J. Immunol. 27:239.
14. Dennehy, K. M., A. Kerstan, A. Bischof, J. H. Park, S. Y. Na, and T. Hunig. 2003. Mitogenic signals through CD28 activate the protein kinase Cθ-NF-κB pathway in primary peripheral T cells. Int. Immunol. 15:655.
15. Reed, J. C., T. Miyashita, M. Cuddy, and D. Cho. 1992. Regulation of p26-bcl-2 protein levels in human peripheral blood lymphocytes. Lab. Invest. 67:443.
16. Latinis, K. M., L. A. Norian, S. L. Eliason, and G. A. Koretzky. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427.
17. Holtz-Heppelmann, C. J., A. Algeciras, A. D. Badley, and C. V. Paya. 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273:4416.
18. Li-Weber, M., O. Laur, A. Hekele, J. Coy, H. Walczak, and P. H. Krammer. 1998. A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur. J. Immunol. 28:2373.
19. Chuvpilo, S., M. Zimmer, A. Ketstan, J. Glockner, A. Avots, C. Escher, C. Fischer, I. Inashkina, E. Jankevics, F. Berberich-Siebelt, et al. 1999. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10:261.
20. Loh, C., J. A. Catew, J. Kim, P. G. Hogan, and A. Rao. 1996. T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1. Mol. Cell Biol. 16:3945.
21. Chuvpilo, S., E. Jankevics, D. Tyrsin, A. Akimzhanov, D. Moroz, M. K. Jha, J. Schulze-Luehrmann, B. Santner-Nanan, E. Feoktistova, T. Konig, et al. 2002. Autoregulation of NIFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16:881.
22. Ranger, A. M., M. R. Hodge, E. M. Gravallese, M. Oukka, L. Davidson, F. W. Alt, F. C. de la Brousse, T. Hoey, M. Grusby, and L. H. Glimcher. 1998. Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity 8:125.
23. L. Mol. Cell Biol. 20:2687.
24. + lymphocytes. J. Immunol. 165:1743.
25. Glasgow, J. N., T. Wood, and J. R. Perez-Polo. 2000. Identification and characterization of nuclear factor κB binding sites in the murine bcl-x promoter. J. Neurochem. 75:1377.
26. Bischof, A., T. Hara, C. H. Lin, A. D. Beyers, and T. Hunig. 2000. Autonomous induction of proliferation, JNK and NF-αB activation in primary resting T cells by mobilized CD28. Eur. J. Immunol. 30:876.
27. Kane, L. P., J. Lin, and A. Weiss. 2002. It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation. Trends Immunol 23:413.